Evidence map›Paper›PMID 39587644›Full record

ArticleDiagnostic pathology2024

FAP-α is an effective tool to evaluate stroma invasion of lung adenocarcinoma.

Siping Xiong, Huan Fan, Yimin Guo, Ruixiang Sun, Hongmei Ma, Yali Xiang, Chao Zeng

Abstract read
In one paragraph

Article in Diagnostic pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siping Xiong *Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Huan Fan *Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Yimin Guo *Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Ruixiang SunDepartment of Clinical Medicine, The Nanshan College of Guangzhou Medical University, Guangzhou, China.
Hongmei MaDepartment of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. mhm20002008@sina.com.
Yali XiangDepartment of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. 25725358@qq.com.
Chao ZengDepartment of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. zengchaosysu@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main difficulty in the diagnosis of atypical in situ adenocarcinoma lies in the distinction between true and false stromal invasion. Moreover, how to identify local alveolar wall collapse in situ lung adenocarcinoma and how to identify whether the trapped adenoid structure around scar is an invasion component have become the key points for accurate diagnosis of lung adenocarcinoma. In the present study, we detected 40 cases of lung adenocarcinoma in situ and 40 cases of invasive adenocarcinoma by using immunohistochemical techniques. We found FAP-α had not immunreactivity in the stroma of adenocarcinoma in situ. However, it stained in the stroma of invasive areas in lung adenocarcinoma. FAP-α staining pattern could represent hyperplastic myofibroblast and demonstrated the true invasion of stroma. This study provides strong evidence that FAP-α is an effective tool to evaluate the presence or absence of stroma invasion of lung adenocarcinoma. Our findings will contribute to the accurate diagnosis of lung invasive adenocarcinoma.

Indexed as

Adenocarcinoma of LungImmunohistochemistryLung NeoplasmsNeoplasm InvasivenessAdenocarcinomaAdenocarcinoma in SituAdultAgedBiomarkers, TumorEndopeptidasesFemaleFibroblast Activation Protein AlphaGelatinasesHumansMaleMembrane ProteinsBiomarkers, TumorEndopeptidasesFibroblast Activation Protein AlphaGelatinasesMembrane ProteinsSerine EndopeptidasesFibroblast activation protein-αLung adenocarcinomaSmooth muscle antibodyStroma invasion

Identifiers

PMID39587644
PMCPMC11587740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.